View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Analysis
April 17, 2014

Pharma Technology Focus – Issue 28

In this issue: A functional cure for HIV, the new clinical data sharing principles, what the industry has learned from the influenza A pandemic five years ago, pain-free injections with microneedles and more

By Berenice Baker

Pharma Technology Focus - Issue 28 | April 2014

The discovery of a new HIV vaccine that may have the ability to stop the progression of the disease and potentially eliminate the virus has stirred up interest across the industry. We explore the potential of FIT Biotech’s functional HIV cure and further steps in the trial.

We also ask whether the new clinical data sharing principles endorsed by EFPIA and PhRMA go far enough and review lessons the industry has learned since the influenza A pandemic five years ago. Moreover, we take a look at a new microneedle array technology that could eliminate the need for deep tissue injections and its possible applications in vaccination and diabetes treatment and find out how Cancer Research UK is trying to tap into the power of citizen science with a new mobile game designed so players unravel gene data, helping with low-level research.

Read the latest issue here.

In this issue

Sharing ResponsiblyBig Pharma is increasing the amount of clinical trial data available to researchers and the public, but do the new principles endorsed by EFPIA and PhRMA go far enough? Elly Earls investigatesClick here to read more.

Injection InnovationNew microneedle arrays could eliminate the need for deep tissue injections with a hypodermic needle. Dr Nicola Davies finds out more about the technology and possible applicationsClick here to read more.

New Hope for HIV PatientsA new form of HIV therapy could drastically reduce the cost of treatment and the patient’s drug burden – but it’s still early days for FIT Biotech’s vaccine, as Elly Earls finds out Click here to read more.

Better PreparedAlmost five years after the influenza A pandemic, nearly all mention flu outbreaks has disappeared from European headlines. Dr Nicola Davies asks what the industry has learned from the pastClick here to read more.

The Game is OnCancer Research UK wants to tap into the power of the crowd with a pioneering new mobile game that feeds genetic data back to researchers. Chris Lo asks what citizen scientists can do that supercomputers can’t Click here to read more.

Drivers of GrowthAs the market for prefilled syringes continues to grow, Klaus Ullherr of Bosch Packaging Technology examines trends that will influence future manufacturing processesClick here to read more.

Next issue preview

Building a new pharmaceutical manufacturing facility represents a significant investment, but new capabilities can bring new opportunities. We find out about the challenges and benefits of investing in state-of-the-art facilities.

We also investigate how the looming patent cliff will affect business in Ireland, where nine of the top ten pharma manufacturers have their headquarters, find out about changing investment trends in the field of new drug research and investigate the debate over drug licensing costs sparked by a new UCL School of Pharmacy report.

Moreover, we review new guidelines for the use of statins to treat high cholesterol and prevent cardiovascular diseases and explore new research into the medical potential of honey.

Digital magazine FAQ

Pharma Technology Focus is available on the iPad and as a free desktop version*. You can download our app or read the latest issue here.

View the archive of back issues.

Sign up for your subscription here.

*Browser compatibility: The desktop version can be viewed in the latest two version of Chrome, Firefox and Safari, as well as in Internet Explorer 9 and 10. Some features may not be compatible with older browser versions.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology